- Report
- July 2025
- 185 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- July 2025
- 180 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- July 2025
- 182 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- July 2025
- 184 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- June 2025
- 185 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- June 2025
- 185 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- June 2025
- 189 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- June 2025
- 183 Pages
Global
From €4012EUR$4,500USD£3,465GBP
- Report
- February 2026
- 200 Pages
Global
From €7124EUR$7,990USD£6,153GBP
- Report
- January 2026
- 80 Pages
Global
From €1783EUR$2,000USD£1,540GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP
- Report
- December 2025
- 200 Pages
Global
From €7088EUR$7,950USD£6,122GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more